9065B |
Quaternary Ammonium Neuromuscular Blocking Agents Screen, Blood |
9065SP |
Quaternary Ammonium Neuromuscular Blocking Agents Screen, Serum/Plasma |
9065TI |
Quaternary Ammonium Neuromuscular Blocking Agents Screen, Tissue |
9065U |
Quaternary Ammonium Neuromuscular Blocking Agents Screen, Urine |
9118B |
Brompheniramine Screen, Blood |
9122B |
Bupropion and Metabolite Screen, Blood |
9122SP |
Bupropion and Metabolite Screen, Serum/Plasma |
9122TI |
Bupropion and Metabolite Screen, Tissue |
9122U |
Bupropion and Metabolite Screen, Urine |
9129B |
Carisoprodol and Metabolite Screen, Blood |
9129FL |
Carisoprodol and Metabolite Screen, Fluid |
9129SP |
Carisoprodol and Metabolite Screen, Serum/Plasma |
9139B |
Clonazepam and Metabolite Screen, Blood |
9139FL |
Clonazepam and Metabolite Screen, Fluid |
9139SP |
Clonazepam and Metabolite Screen, Serum/Plasma |
9139U |
Clonazepam and Metabolite Screen, Urine |
9142B |
Cyanide Screen, Blood |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9159B |
Disopyramide Screen, Blood |
9159SP |
Disopyramide Screen, Serum/Plasma |
9163B |
Doxylamine Screen, Blood |
9163SP |
Doxylamine Screen, Serum/Plasma |
9171B |
Ethosuximide Screen, Blood |
9171SP |
Ethosuximide Screen, Serum/Plasma |
9171U |
Ethosuximide Screen, Urine |
9182B |
Haloperidol Screen, Blood |
9182SP |
Haloperidol Screen, Serum/Plasma |
9188B |
Ketamine and Metabolite Screen, Blood |
9188SP |
Ketamine and Metabolite Screen, Serum/Plasma |
9188U |
Ketamine and Metabolite Screen, Urine |
9190B |
Ketoacidosis Screen, Postmortem, Blood (Forensic) |
9190FL |
Ketoacidosis Screen, Postmortem, Fluid (Forensic) |
9200SP |
Mepivacaine Screen, Serum/Plasma |
9205SP |
Dextro / Levo Methorphan Screen, Serum/Plasma |
9205U |
Dextro / Levo Methorphan Screen - Total, Urine |
9206U |
Dextrorphan / Levorphanol Screen - Total, Urine |
9211B |
Mexiletine Screen, Blood |
9211SP |
Mexiletine Screen, Serum/Plasma |
9215B |
Nitrazepam and Metabolite Screen, Blood |
9215SP |
Nitrazepam and Metabolite Screen, Serum/Plasma |
9219B |
Orphenadrine Screen, Blood |
9222B |
Papaverine Screen, Blood |
9249B |
Pseudoephedrine vs Ephedrine Differentiation Screen, Blood |
9249U |
Pseudoephedrine vs Ephedrine Differentiation Screen, Urine |
9254B |
Quinine/Quinidine Screen, Blood |
9261B |
Scopolamine Screen, Blood |
9261SP |
Scopolamine Screen, Serum/Plasma |
9261U |
Scopolamine Screen, Urine |
9276B |
Thiothixene (Cis Isomer) Screen, Blood |
9276SP |
Thiothixene (Cis Isomer) Screen, Serum/Plasma |
9276U |
Thiothixene (Cis Isomer) Screen, Urine |
9293B |
Methylenedioxymethamphetamine and Metabolite Screen, Blood |
9293SP |
Methylenedioxymethamphetamine and Metabolite Screen, Serum/Plasma |
9293U |
Methylenedioxymethamphetamine and Metabolite Screen, Urine |
9306U |
Anabolic Steroids Screen, Urine |
9318U |
Diuretics Screen, Urine |
9326B |
Gamma-Hydroxybutyric Acid Screen, Blood |
9326FL |
Gamma-Hydroxybutyric Acid Screen, Fluid |
9326SP |
Gamma-Hydroxybutyric Acid Screen, Serum/Plasma |
9326U |
Gamma-Hydroxybutyric Acid Screen, Urine |
9327B |
Propane, Blood |
9329B |
Benzodiazepines Panel, Blood |
9329FL |
Benzodiazepines Panel, Fluid |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9329SP |
Benzodiazepines Panel, Serum/Plasma |
9329TI |
Benzodiazepines Panel, Tissue |
9329U |
Benzodiazepines Panel, Urine |
9341B |
Flunitrazepam and Metabolites Screen, Blood |
9341SP |
Flunitrazepam and Metabolites Screen, Serum/Plasma |
9341TI |
Flunitrazepam and Metabolites Screen, Tissue |
9341U |
Flunitrazepam and Metabolites Screen, Urine |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9401B |
Chloral Hydrate Screen, Blood |
9401SP |
Chloral Hydrate Screen, Serum/Plasma |
9401U |
Chloral Hydrate Screen, Urine |
9404B |
Nicotine and Metabolite Screen, Blood |
9404SP |
Nicotine and Metabolite Screen, Serum/Plasma |
9404U |
Nicotine and Metabolite with Anabasine Screen, Urine |
9431B |
Antidepressants Screen, Blood |
9431SP |
Antidepressants Screen, Serum/Plasma |
9431U |
Antidepressants Screen, Urine |
9435B |
Doxepin and Metabolite Screen, Blood |
9435U |
Doxepin and Metabolite Screen, Urine |
9443B |
Glutethimide Screen, Blood |
9443SP |
Glutethimide Screen, Serum/Plasma |
9522B |
Methamphetamine and Amphetamine Screen, Blood |
9522SP |
Methamphetamine and Amphetamine Screen, Serum/Plasma |
9522U |
Methamphetamine and Amphetamine Screen, Urine |
9560B |
Synthetic Cannabinoids Screen, Blood |
9562U |
Synthetic Cannabinoid Metabolites Screen - Expanded, Urine |